The tweet was deleted by the author.
But we saved everything 🙂.
Stereotaxis reported revenue of 32.4 million, marking growth exceeding 20 percent compared to the previous year.
The company announced regulatory approvals for its GenesisX, MAGiC, and MAGiC Sweep technologies. Stereotaxis also established key manufacturing and commercial foundations as it prepares to launch new technology and pursue further business expansion. The company emphasized its commitment to accelerating growth and driving innovation within its sector.
Stereotaxis’s ongoing momentum builds on its longstanding efforts to enhance patient and physician safety, as highlighted by its advancements in robotic technology that shields patients and doctors from radiation during complex procedures. The company’s push for broader adoption is further underscored by past initiatives to offer practitioners a direct experience of RoboticEP benefits through interactive demonstration, reinforcing its position at the forefront of innovation in interventional medicine.